+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“The Global Fetal & Neonatal Care Equipment market is estimated to be worth $8.3bn in 2023” says new Visiongain report

05 October 2018
Pharma

Visiongain has launched a new pharma report: Global Fetal & Neonatal Care Equipment Market Forecast 2018-2028: Fetal, Neonatal, Ultrasound Devices, Fetal MRI Systems, Fetal Monitors, Fetal Pulse Oximeters, Warmer & Incubator, Phototherapy Equipment, Respiratory Devices, Neonatal Monitoring Devices, Hospitals, Clinics, Others

Fetal and neonatal care are emerging as a vital aspect in medical healthcare industry. The fetal and neonatal care comprises measures from early embryonic development through full foetus development and philosophical changes at the time of birth and one month post-delivery as a new born infant. Both fetal and neonatal growth and development are interconnected to the genetic and environmental factors. According to American Academy of Paediatrics, approximately 10% of the infants need birth assistance and ~ 1% need extensive care at the time of birth.

The lead analyst of the report commented "The fetal and neonatal care equipment market is anticipated to witness a strong growth during the forecast period. The key factor attributing to the growth of the market are increasing incidence and prevalence of pre-term birth, still birth, neonatal health complication, and other mother and neonatal pregnancy associated diseases.

The warmer & incubator held the largest share in Neonatal Care Equipment market and is expected to continue leading the market during the forecast period. However, with the increasing awareness for neonates vital analysis, the neonatal monitoring devices is anticipated to witness the second highest growth during the forecast period."

Leading companies featured in the report include Dragerwerk AG & Co. KGaA, Fisher & Paykel, GE Healthcare, Masimo Corporation, Medtronic plc, Natus Medical Inc., Philips Healthcare, Phoenix Medical Systems Pvt. Ltd.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read

Visiongain Publishes Female Health Tech Market Report 2024-2034

The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.

05 April 2024

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034

The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034

26 March 2024

Read